SWAN scale for ADHD trait-based genetic research: a validity and polygenic risk study.


Journal

Journal of child psychology and psychiatry, and allied disciplines
ISSN: 1469-7610
Titre abrégé: J Child Psychol Psychiatry
Pays: England
ID NLM: 0375361

Informations de publication

Date de publication:
09 2019
Historique:
accepted: 13 12 2018
pubmed: 26 3 2019
medline: 5 9 2020
entrez: 26 3 2019
Statut: ppublish

Résumé

Population-based samples with valid, quantitative and genetically informative trait measures of psychopathology could be a powerful complement to case/control genetic designs. We report the convergent and predictive validity of the parent- and self-report versions of the Strengths and Weaknesses of ADHD Symptoms and Normal Behavior Rating Scale (SWAN). We tested if SWAN scores were associated with ADHD diagnosis, ADHD polygenic risk, as well as traits and polygenic risk for disorders that co-occur with ADHD: anxiety and obsessive-compulsive disorder (OCD). We collected parent- and self-report SWAN scores in a sample of 15,560 children and adolescents (6-17 years) recruited at a science museum (Spit for Science sample). We established age and sex norms for the SWAN. Sensitivity-specificity analyses determined SWAN cut-points that discriminated those with and without a reported ADHD diagnosis. These cut-points were validated in a clinic sample (266 ADHD cases; 36 controls). Convergent validity was established using the Conners' parent- and self-report scales. Using Spit for Science participants with genome-wide data (n = 5,154), we tested if low, medium and high SWAN scores were associated with polygenic risk for ADHD, OCD and anxiety disorders. Parent- and self-report SWAN scores showed high convergent validity with Conners' scales and distinguished ADHD participants with high sensitivity and specificity in the Spit for Science sample. In a clinic sample, the Spit for Science cut-points discriminated ADHD cases from controls with a sensitivity of 84% and specificity of 92%. High SWAN scores and scores above the Spit for Science cut-points were significantly associated with polygenic risk for ADHD. SWAN scores were not associated with polygenic risk for OCD or anxiety disorders. Our study supports the validity of the parent- and self-report SWAN scales and their potential in ADHD population-based genetic research.

Sections du résumé

BACKGROUND
Population-based samples with valid, quantitative and genetically informative trait measures of psychopathology could be a powerful complement to case/control genetic designs. We report the convergent and predictive validity of the parent- and self-report versions of the Strengths and Weaknesses of ADHD Symptoms and Normal Behavior Rating Scale (SWAN). We tested if SWAN scores were associated with ADHD diagnosis, ADHD polygenic risk, as well as traits and polygenic risk for disorders that co-occur with ADHD: anxiety and obsessive-compulsive disorder (OCD).
METHODS
We collected parent- and self-report SWAN scores in a sample of 15,560 children and adolescents (6-17 years) recruited at a science museum (Spit for Science sample). We established age and sex norms for the SWAN. Sensitivity-specificity analyses determined SWAN cut-points that discriminated those with and without a reported ADHD diagnosis. These cut-points were validated in a clinic sample (266 ADHD cases; 36 controls). Convergent validity was established using the Conners' parent- and self-report scales. Using Spit for Science participants with genome-wide data (n = 5,154), we tested if low, medium and high SWAN scores were associated with polygenic risk for ADHD, OCD and anxiety disorders.
RESULTS
Parent- and self-report SWAN scores showed high convergent validity with Conners' scales and distinguished ADHD participants with high sensitivity and specificity in the Spit for Science sample. In a clinic sample, the Spit for Science cut-points discriminated ADHD cases from controls with a sensitivity of 84% and specificity of 92%. High SWAN scores and scores above the Spit for Science cut-points were significantly associated with polygenic risk for ADHD. SWAN scores were not associated with polygenic risk for OCD or anxiety disorders.
CONCLUSIONS
Our study supports the validity of the parent- and self-report SWAN scales and their potential in ADHD population-based genetic research.

Identifiants

pubmed: 30908652
doi: 10.1111/jcpp.13032
doi:

Types de publication

Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

988-997

Subventions

Organisme : CIHR
ID : MOP-106573
Pays : Canada
Organisme : CIHR
ID : MOP-93696
Pays : Canada

Informations de copyright

© 2019 Association for Child and Adolescent Mental Health.

Auteurs

Christie L Burton (CL)

Neurosciences and Mental Health Program, Hospital for Sick Children, Toronto, ON, Canada.

Leah Wright (L)

Neurosciences and Mental Health Program, Hospital for Sick Children, Toronto, ON, Canada.

Janet Shan (J)

Neurosciences and Mental Health Program, Hospital for Sick Children, Toronto, ON, Canada.

Bowei Xiao (B)

Genetics and Genome Biology Program, Hospital for Sick Children, Toronto, ON, Canada.

Annie Dupuis (A)

Clinical Research Services, Hospital for Sick Children, Toronto, ON, Canada.
Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada.

Tara Goodale (T)

Neurosciences and Mental Health Program, Hospital for Sick Children, Toronto, ON, Canada.

S-M Shaheen (SM)

Mathison Centre for Mental Health Research and Education, University of Calgary, Calgary, AB, Canada.
Departments of Psychiatry & Medical Genetics, Hotchkiss Brain Institute, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.

Elizabeth C Corfield (EC)

Neurosciences and Mental Health Program, Hospital for Sick Children, Toronto, ON, Canada.
Department of Psychiatry, University of Toronto, Toronto, ON, Canada.

Paul D Arnold (PD)

Genetics and Genome Biology Program, Hospital for Sick Children, Toronto, ON, Canada.
Mathison Centre for Mental Health Research and Education, University of Calgary, Calgary, AB, Canada.
Departments of Psychiatry & Medical Genetics, Hotchkiss Brain Institute, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.

Russell J Schachar (RJ)

Neurosciences and Mental Health Program, Hospital for Sick Children, Toronto, ON, Canada.
Department of Psychiatry, University of Toronto, Toronto, ON, Canada.
Institute of Medical Science, University of Toronto, Toronto, ON, Canada.

Jennifer Crosbie (J)

Neurosciences and Mental Health Program, Hospital for Sick Children, Toronto, ON, Canada.
Department of Psychiatry, University of Toronto, Toronto, ON, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH